| [1] |
Chen W,Zheng R,Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016，66(2)：115-132.
|
| [2] |
Rudolph A,Chang-Claude J,Schmidt MK. Gene-environment interaction and risk of breast cancer [J]. Br J Cancer, 2016，114(2)：125-133.
|
| [3] |
Elkum N,Al-Tweigeri T,Ajarim D, et al. Obesity is a significant risk factor for breast cancer in Arab women[J]. BMC Cancer，2014，14: 788.
|
| [4] |
Donohoe CL,Doyle SL,Reynolds JV. Visceral adiposity, insulin resistance and cancer risk[J]. Diabetol Metab Syndr, 2011，3：12.
|
| [5] |
No authors listed. Obesity: preventing and managing the global epidemic. Report of a WHO consultation [J]. World Health Organ Tech Rep Ser, 2000，894：i-xii, 1-253.
|
| [6] |
Wang Y,Mi J,Shan XY, et al. Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China[J]. Int J Obes (Lond), 2007，31(1)：177-188.
|
| [7] |
Wolk A,Gridley G,Svensson M, et al. A prospective study of obesity and cancer risk (Sweden) [J]. Cancer Causes Control, 2001，12(1)：13-21.
|
| [8] |
Huang Z,Hankinson SE,Colditz GA, et al. Dual effects of weight and weight gain on breast cancer risk[J]. JAMA, 1997，278(17)：1407-1411.
|
| [9] |
Ewertz M,Jensen MB,Gunnarsdóttir Ká，et al. Effect of obesity on prognosis after early-stage breast cancer[J]. J Clin Oncol, 2011，29(1)：25-31.
|
| [10] |
Lorincz AM,Sukumar S. Molecular links between obesity and breast cancer[J]. Endocr Relat Cancer, 2006，13(2)：279-292.
|
| [11] |
Scherer PE,Williams S,Fogliano M, et al. A novel serum protein similar to C1q, produced exclusively in adipocytes[J]. J Biol Chem, 1995, 270(45): 26 746-26 749.
|
| [12] |
Saito K,Tobe T,Minoshima S, et al. Organization of the gene for gelatin-binding protein (GBP28)[J]. Gene，1999, 229(1/2): 67-73.
|
| [13] |
Ye J,Jia J,Dong S, et al. Circulating adiponectin levels and the risk of breast cancer: a meta-analysis[J]. Eur J Cancer Prev，2014，23(3): 158-165.
|
| [14] |
Berg AH,Combs TP,Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism[J]. Trends Endocrinol Metab，2002，13(2): 84-89.
|
| [15] |
Ahmed SD,Khanam A,Sultan N, et al. Serum adiponectin level association with breast cancer risk: evidence from a case-control study[J]. Asian Pac J Cancer Prev, 2015，16(12)：4945-4948.
|
| [16] |
Waki H,Yamauchi T,Kamon J, et al. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin[J]. J Biol Chem, 2003，278(41)：40 352-40 363.
|
| [17] |
Mauro L,Pellegrino M,De Amicis F, et al. Evidences that estrogen receptor α interferes with adiponectin effects on breast cancer cell growth[J]. Cell Cycle，2014，13(4)：553-564.
|
| [18] |
Kadowaki T,Yamauchi T. Adiponectin and adiponectin receptors [J]. Endocr Rev, 2005，26(3)：439-451.
|
| [19] |
Mauro L,Naimo GD,Ricchio E, et al. Cross-talk between adiponectin and IGF-IR in breast cancer[J]. Front Oncol, 2015，5：157.
|
| [20] |
Lindsay RS,Funahashi T,Krakoff J, et al. Genome-wide linkage analysis of serum adiponectin in the Pima Indian population[J]. Diabetes, 2003，52(9)：2419-2425.
|
| [21] |
Pajvani UB,Du X,Combs TP, et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity[J]. J Biol Chem, 2003，278(11)：9073-9085.
|
| [22] |
Maeda N,Takahashi M,Funahashi T, et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein[J]. Diabetes, 2001, 50(9): 2094-2099.
|
| [23] |
Weyer C,Funahashi T,Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia[J]. J Clin Endocrinol Metab, 2001，86(5)：1930-1935.
|
| [24] |
Yang WS,Lee WJ,Funahashi T, et al. Plasma adiponectin levels in overweight and obese Asians [J]. Obes Res, 2002，10(11)：1104-1110.
|
| [25] |
Liu M,Liu F. Transcriptional and post-translational regulation of adiponectin[J]. Biochem J, 2009，425(1)：41-52.
|
| [26] |
Fabian CJ. Adiponectin: a risk biomarker and attractive target for chemoprevention[J]. J Clin Oncol, 2012，30(2)：124-126.
|
| [27] |
Kaklamani VG,Hoffmann TJ,Thornton TA, et al. Adiponectin pathway polymorphisms and risk of breast cancer in African Americans and Hispanics in the Women’s Health Initiative[J]. Breast Cancer Res Treat, 2013，139(2)：461-468.
|
| [28] |
Villarreal-Molina MT,Antuna-Puente B. Adiponectin: anti-inflammatory and cardioprotective effects [J]. Biochimie, 2012，94(10)：2143-2149.
|
| [29] |
An W,Bai Y,Deng SX, et al. Adiponectin levels in patients with colorectal cancer and adenoma: a meta-analysis[J]. Eur J Cancer Prev, 2012，21(2)：126-133.
|
| [30] |
Xu XT,Xu Q,Tong JL, et al. Meta-analysis: circulating adiponectin levels and risk of colorectal cancer and adenoma[J]. J Dig Dis, 2011，12(4)：234-244.
|
| [31] |
Petridou E,Mantzoros C,Dessypris N, et al. Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece[J]. J Clin Endocrinol Metab, 2003，88(3)：993-997.
|
| [32] |
Miyoshi Y,Funahashi T,Kihara S, et al. Association of serum adiponectin levels with breast cancer risk[J]. Clin Cancer Res, 2003，9(15)：5699-5704.
|
| [33] |
Chen DC,Chung YF,Yeh YT, et al. Serum adiponectin and leptin levels in Taiwanese breast cancer patients[J]. Cancer Lett, 2006，237(1)：109-114.
|
| [34] |
Macis D,Guerrieri-Gonzaga A,Gandini S. Circulating adiponectin and breast cancer risk: a systematic review and meta-analysis[J]. Int J Epidemiol, 2014，43(4)：1226-1236.
|
| [35] |
Gunter MJ,Wang T,Cushman M, et al. Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk[J]. J Natl Cancer Inst, 2015，107(9): djv169.
|
| [36] |
Liu LY,Wang M,Ma ZB, et al. The role of adiponectin in breast cancer: a meta-analysis[J]. PLoS One, 2013，8(8)：e73183.
|
| [37] |
Guo MM,Duan XN,Cui SD, et al. Circulating high-molecular-weight (HMW) adiponectin level is related with breast cancer risk better than total adiponectin: A case-control study[J]. PLoS One, 2015，10(6)：e0129246.
|
| [38] |
Ouchi N,Kobayashi H,Kihara S, et al. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells [J]. J Biol Chem, 2004，279(2)：1304-1309.
|
| [39] |
Dos Santos E,Benaitreau D,Dieudonne MN, et al. Adiponectin mediates an antiproliferative response in human MDA-MB 231 breast cancer cells[J]. Oncol Rep, 2008，20(4)：971-977.
|
| [40] |
Wang Y,Lam JB,Lam KS, et al. Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice[J]. Cancer Res, 2006，66(23)：11 462-11 470.
|
| [41] |
Grossmann ME,Nkhata KJ,Mizuno NK, et al. Effects of adiponectin on breast cancer cell growth and signaling [J]. Br J Cancer, 2008，98(2)：370-379.
|
| [42] |
Dieudonne MN,Bussiere M,Dos Santos E, et al. Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells[J]. Biochem Biophys Res Commun, 2006，345(1)：271-279.
|
| [43] |
Kim KY,Baek A,Hwang JE, et al. Adiponectin-activated AMPK stimulates dephosphorylation of AKT through protein phosphatase 2A activation[J]. Cancer Res, 2009, 69(9): 4018-4026.
|
| [44] |
Jardé T,Caldefie-Chézet F,Goncalves-Mendes N, et al. Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies[J]. Endocr Relat Cancer, 2009，16(4)：1197-1210.
|
| [45] |
Ogunwobi OO,Beales IL. Globular adiponectin, acting via adiponectin receptor-1, inhibits leptin-stimulated oesophageal adenocarcinoma cell proliferation[J]. Mol Cell Endocrinol, 2008，285(1/2)：43-50.
|
| [46] |
Wang Y,Lam KS,Xu JY, et al. Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner[J]. J Biol Chem, 2005，280(18)：18 341-18 347.
|
| [47] |
Arita Y,Kihara S,Ouchi N, et al. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell [J]. Circulation, 2002，105(24)：2893-2898.
|
| [48] |
Nkhata KJ,Ray A,Schuster TF, et al. Effects of adiponectin and leptin co-treatment on human breast cancer cell growth[J]. Oncol Rep, 2009，21(6)：1611-1619.
|
| [49] |
Grossmann ME,Ray A,Dogan S, et al. Balance of adiponectin and leptin modulates breast cancer cell growth[J]. Cell Res, 2008，18(11)：1154-1156.
|
| [50] |
Shrestha A,Nepal S,Kim MJ, et al. Critical role of AMPK/FoxO3A axis in globular adiponectin-induced cell cycle arrest and apoptosis in cancer cells[J]. J Cell Physiol, 2016，231(2)：357-369.
|
| [51] |
Denzel MS,Hebbard LW,Shostak G, et al. Adiponectin deficiency limits tumor vascularization in the MMTV-PyV-mT mouse model of mammary cancer[J]. Clin Cancer Res, 2009，15(10)：3256-3264.
|
| [52] |
Landskroner-Eiger S,Qian B,Muise ES, et al. Proangiogenic contribution of adiponectin toward mammary tumor growth in vivo[J]. Clin Cancer Res, 2009，15(10)：3265-3276.
|
| [53] |
Hwang MS,Yu N,Stinson SY, et al. miR-221/222 targets adiponectin receptor 1 to promote the epithelial-to-mesenchymal transition in breast cancer[J]. PLoS One, 2013，8(6)：e66502.
|